How much funding has Terray Therapeutics raised?

Terray Therapeutics has raised $180.0M in total funding, most recently a Series B round.

Who are Terray Therapeutics's investors?

Terray Therapeutics's investors include Bedford Ridge Capital, Madrona Venture, nVentures.

When was Terray Therapeutics founded?

Terray Therapeutics was founded in 2019.

Where is Terray Therapeutics headquartered?

Terray Therapeutics is headquartered in Monrovia, California, United States.

What industry is Terray Therapeutics in?

Terray Therapeutics operates in Artificial Intelligence, Biotech, Healthcare, Drug Discovery.

How many employees does Terray Therapeutics have?

Terray Therapeutics has 51-200 employees.

Terray Therapeutics

formerly Terray

Everything small molecule drug discovery should be.

Monrovia, United States · Founded 2019 · $180.0M raised

Artificial Intelligence

Biotech

Healthcare

Drug Discovery

Headquarters: Monrovia, California
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: terray.com
Total Funding: $180.0M
Last Round: $120.0M Series BOct 2024
Rounds: 2

About

Terray Therapeutics is an AI-native biotech company that invents its own miniaturized chemistry hardware, builds proprietary datasets, and designs custom AI models to fundamentally reimagine small molecule drug discovery. Founded in 2019, it has partnered with Gilead to discover and develop novel small molecule therapies across multiple targets.

Summary

Terray Therapeutics is an Artificial Intelligence company based in Monrovia, United States, founded in 2019. It has raised $180.0M in total across 2 rounds, most recently a $120.0M Series B round in Oct 2024. Investors include Bedford Ridge Capital, Madrona Venture and nVentures.

LinkedIn X (Twitter)GitHub